Trade

with

Luminex Corp
(NASDAQ: LMNX)
AdChoices
20.51
+0.27
+1.33%
After Hours :
-
-
-

Open

20.50

Previous Close

20.24

Volume (Avg)

500 (221.90k)

Day's Range

20.38-20.51

52Wk Range

15.74-21.69

Market Cap.

866.83M

Dividend Rate ( Yield )

-

Beta

0.59

Shares Outstanding

42.76M

P/E Ratio (EPS)

51.55 (0.39)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Medical Instruments & Supplies
Highlights
Analyst Recommendation: Hold
    • Revenue

    • 213.42M

    • Net Income

    • 7.10M

    • Market Cap.

    • 866.83M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 7.61

    • PEG (Price/Earnings Growth) Ratio

    • 1.75

    • Beta

    • 0.59

    • Forward P/E

    • 44.05

    • Price/Sales

    • 3.92

    • Price/Book Value

    • 3.03

    • Price/Cash flow

    • 20.24

      • EBITDA

      • 27.42M

      • Return on Capital %

      • 5.53

      • Return on Equity %

      • 6.19

      • Return on Assets %

      • 5.53

      • Book Value/Share

      • 6.68

      • Shares Outstanding

      • 42.76M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Hold
        • 1 Year Price Target

        • 19.00

        • Credit Rating

        • -

        • Analysts

        • 1

        • EPS Estimate

        • 0.46

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 2.50

          • 10.42

          • Net Income

            YTD/YTD (last year)

          • -42.80

          • -15.59

          • Net Income

            Q/Q (last year)

          • 27.90

          • -8.93

          • Sales (Revenue)

            5-Year Annual Average

          • 15.36

          • 12.51

          • Net Income

            5-Year Annual Average

          • 18.30

          • 4.16

          • Dividends

            5-Year Annual Average

          • -

          • 0.97

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 66.80

            • 52.83

            • Pre-Tax Margin

            • 9.55

            • 15.96

            • Net Profit Margin

            • 7.61

            • 12.40

            • Average Gross Margin

              5-Year Annual Average

            • 68.20

            • 52.66

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 8.10

            • 18.40

            • Average Net Profit Margin

              5-Year Annual Average

            • 7.10

            • 93.46B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.62

              • Current Ratio

              • 6.94

              • 1.97

              • Quick Ratio

              • 5.17

              • 1.16

              • Interest Coverage

              • 672.74

              • 10.47

              • Leverage Ratio

              • 1.11

              • 2.38

              • Book Value/Share

              • 6.68

              • 12.11

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 51.55

                • 35.97

                • P/E Ratio 5-Year High

                • 65.47

                • 279.76

                • P/E Ratio 5-Year Low

                • 32.37

                • 148.87

                • Price/Sales Ratio

                • 3.92

                • 3.33

                • Price/Book Value

                • 3.03

                • 4.16

                • Price/Cash Flow Ratio

                • 20.24

                • 17.27

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • 6.19

                    (4.90)

                  • 17.93

                    (21.42)

                  • Return on Assets %

                    (5-Year Average)

                  • 5.53

                    (4.30)

                  • 7.35

                    (9.50)

                  • Return on Capital %

                    (5-Year Average)

                  • 6.18

                    (4.70)

                  • 10.24

                    (13.59)

                  • Income/Employee

                  • 22.71k

                  • 25.65k

                  • Inventory Turnover

                  • 2.24

                  • 2.66

                  • Asset Turnover

                  • 0.73

                  • 0.59

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  4.77M
                  Operating Margin
                  2.23
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  20.24
                  Ownership

                  Institutional Ownership

                  78.57%

                  Top 10 Institutions

                  51.53%

                  Mutual Fund Ownership

                  39.39%

                  Float

                  77.00%

                  5% / Insider Ownership

                  8.62%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Champlain - Small Cap Equity

                  •  

                    1,682,710

                  • -2.18

                  • 3.93

                  • Villere Balanced Fund

                  •  

                    1,408,444

                  • 0.00

                  • 3.29

                  • ClearBridge Small Cap Growth Fund

                  •  

                    1,167,877

                  • -1.05

                  • 2.73

                  • Vanguard Explorer Fund

                  •  

                    811,260

                  • -19.36

                  • 1.95

                  • PrimeCap Odyssey Aggressive Growth Fund

                  •  

                    777,638

                  • -16.37

                  • 1.86

                  • iShares Core S&P Small-Cap (AU)

                  •  

                    770,274

                  • 0.57

                  • 1.83

                  • Vanguard Small Cap Index

                  •  

                    669,268

                  • 0.36

                  • 1.57

                  • Champlain Small Company Fund

                  •  

                    625,000

                  • 6.84

                  • 1.46

                  • Vanguard Total Stock Mkt Idx

                  •  

                    616,650

                  • 0.00

                  • 1.44

                  • PowerShares Dynamic Biotech&Genome Port

                  •  

                    583,559

                  • 0.00

                  • 1.42

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Villere St Denis J & Co Llc

                  •  

                    5,579,209

                  • +0.37%

                  • 13.38

                  • Vanguard Group, Inc.

                  •  

                    2,543,611

                  • -6.69%

                  • 6.10

                  • BlackRock Fund Advisors

                  •  

                    2,416,868

                  • -5.41%

                  • 5.80

                  • PRIMECAP Management Company

                  •  

                    2,040,232

                  • -14.50%

                  • 4.89

                  • Champlain Investment Partners, LLC

                  •  

                    1,850,120

                  • +0.97%

                  • 4.44

                  • Kalmar Investments Inc

                  •  

                    1,695,122

                  • -0.37%

                  • 4.06

                  • St. Denis J. Villere & Company, LLC

                  •  

                    1,508,944

                  • 0.00%

                  • 3.53

                  • Investment Management of Virginia, LLC

                  •  

                    1,417,289

                  • -2.89%

                  • 3.31

                  • ClearBridge Advisors, LLC

                  •  

                    1,293,718

                  • +0.41%

                  • 3.10

                  • Legg Mason Partners Fund Advisor, LLC

                  •  

                    1,248,847

                  • -0.98%

                  • 2.92

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Medical Instruments & Supplies

                  Type

                  Speculative Growth

                  Style

                  Small Core

                  Luminex Corp was incorporated under the laws of the State of Texas in May 1995, and was reincorporated in the State of Delaware in July 2000. The Company develops, manufactures and sells proprietary biological testing technologies an...mored products with applications throughout the life sciences and diagnostics industries. The Company has two reportable segments; TSP segment and ARP segment. The TSP segment represents the Company’s base business and consists of system sales to partners, raw bead sales, royalties, service and support of the technology, and other miscellaneous items and the ARP segment is involved in the development and sale of assays on xMAP technology for use on Luminex’s installed base of systems, as well as the sale of automated punching systems. The Company also develops and manufactur...morees the proprietary xMAP laboratory instrumentation and the proprietary xMAP microspheres and sells them. The ARP segment is mainly involved in the development and sale of assays utilizing xMAP technology on its installed base of systems. The ARP segment is mainly focused on multiplexed applications for the human molecular clinical diagnostics market. The Company’s diagnostic market competitors include Abbott Laboratories, Beckman Coulter, Inc., Celera Corporation, Cepheid, Johnson & Johnson, Roche Diagnostics, Siemens Medical, and Hologic, Inc. It currently owns 281 issued patents, including 110 issued patents in the United States. The Company’s trademark includes Luminex®, xMAP®, xTAG®, Luminex® 100/200™ MicroPlex®, MAGPIX®, MagPlex®, SeroMAP™, xPONENT®, FlexmiR®, NeoPlex4™, LumAvidin® Et cetera. The Company is subject to federal, state and local laws and regulations relating to the protection of human health and the environment.lessless

                  Key People

                  Nachum Shamir

                  CEO/President/Director

                  G. Walter Loewenbaum,II

                  Chairman of the Board/Director

                  Harriss T. Currie

                  CFO/Chief Accounting Officer/Senior VP, Divisional/Treasurer

                  Fred C. Goad,Jr

                  Director

                  Jim D. Kever

                  Director

                  • Luminex Corp

                  • 12212 Technology Boulevard

                  • Austin, TX 78727

                  • USA.Map

                  • Phone: +1 512 219-8020

                  • Fax: +1 512 219-5195

                  • luminexcorp.com

                  Incorporated

                  1995

                  Employees

                  731

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: